A Phase IIIi Multicentre Double-Blinded Randomised Trial of Celecoxib Versus Palcebo in Primary Breast Cancer Patients (REACT)

Project Details

StatusFinished
Effective start/end date1/03/1031/12/22

Funding

  • Other: £184,290.00